In reaction to strong earnings/guidance: GBX +3.2%.
Financial related names showing strength: ING +5% (upgraded to Outperform from Neutral at Exane BNP Paribas ), RBS +4.3%, ING +3.6%, BBVA +2%, SAN +1.9%, DB +1.8% (derivatives portfolio is being probed by German regulators, according to reports ), BCS +1.3%, BAC +0.8%, JPM +0.7%, C +0.7%, HBC +0.3%.
Select metals/mining stocks ticking higher: VALE +2.1%, MT +1.8%, RIO +1.5% (Some RIO mines may be purchased by Coal India, according to reports), BBL +1.3%, BHP +0.9%.
Select Japan related names ticking higher after the BOJ has announced a open-ended bond purchase plan: SMFG +5.2%, NMR +5.1%, TM +3.5%, MTU +3.4%, HMC +3%.
A few telcom names are higher: TEF +2.4%, TI +2.1%, FTE +1.1%
Other news: NAVB +6.7% (Navidea Biopharmaceuticals reports positive top-line results from interim analysis of Lymphoseek Phase 3 clinical trial in head and neck cancer), RDY +3.2% (light volume, Dr. Reddy's launches Zoledronic Acid Injection), FB +0.6% (ahead of expected Android launch), .
Analyst comments: NKA +6.9% (light volume, upgraded to Outperform from Market Perform at Wells Fargo, upgraded to Equal Weight from Underweight at Barclays), PT +6.3% (added to Conviction Buy at Goldman), PANL +3.1% (upgraded to Buy at Needham), FNSR +3.1% (upgraded to Buy from Neutral at Lazard), SRPT +2.8% (initiated with Outperform at Baird), PNRA +2.1% (added to Conviction Buy list at Goldman), TMH +1.8% (added to Conviction Buy list and upgraded from Neutral at Goldman ), BRO +1.5% (ticking higher, upgraded to Neutral from Sell at Goldman), EAT +0.8% (upgraded to Buy from Neutral at Goldman), AAPL +0.4% (initiated with a Buy at Lazard)
Gapping down
In reaction to disappointing earnings/guidance: CPWR -2.7%, MIND -2.5%, LULU -1.5%.
A few European drug names are lower: NVS -1.3%, AZN -1.1%
Other news: MACK -7.4% (announces top-line results from a single arm Phase 2 advanced lung cancer study in patients with resistance to an anti-EGFR tyrosine kinase inhibitor -- one cohort of a Phase 2 non-small cell lung cancer study did not meet its primary endpoint), LSE -2.4% (announced the commencement of a public offering of 6,500,000 shares of its common stock), STM -2.2% and ARMH -1.9% (still checking), CCL -1.9% (continued weakness on Triumph news), DEO -1.4% (still checking), RDS.A -0.6% (Royal Dutch Shell Geelong Australia refinery is now for sale, according to reports ).
Analyst comments: LCC -1.8% (downgraded to Neutral from Buy at BofA/Merrill), ARUN -1.8% (downgraded to Neutral from Buy at UBS), AVA -1% (ticking lower, downgraded to Neutral from Buy at UBS), MSFT -0.6% (downgraded to Neutral from Buy at BofA/Merrill)
Торговые идеи NYSEи NASDAQ:
CPWR – компания понизила прогноз по EPS и выручке на 4 квартал. Лонг выше 11.75, ниже 11.50 смотрим акцию в шорт с потенциалом от 25 до 50 центов.
CCL – компания из индекса SP500. На премаркете небольшой гэп вниз, ниже 32.75 смотрим акцию в шорт.
GBX – смешанный отчет, ожидают FY13 таким же как FY12. Премаркет малоактивный, но на открытии возможна хорошая волатильность. Ключевой уровень – вчерашний максимум 23.00 и минимум 21.50.
Спайдер торгуется на премаркете с незначительным понижением.
Европейские индексы на отрицательной территории.
Nikkei +3.0 %, Shanghai около нулевой отметки.
SPY (внутридневной график) рост на премаркете. Сопротивление 157.00. Поддержка: 156.60
Ожидаемая макроэкономическая статистика:
MBA Mortgage Index (7am)- Prior +7.7%
March ADP Employment Change (8:15am)- Briefing.com consensus 197K
March ISM Services (10am)- Briefing.com consensus 55.5, February 56.0
Petroleum Inventories (10:30am)
Премаркет NYSE/NASDAQ:
Gapping up
In reaction to strong earnings/guidance: CALL +15.1%, MON +1.9%, GIII +1.7%.
M&A news: OMPI +11.5% (Obagi Medical and Valeant Pharmaceuticals agree on an increased offer price of $24.00 per share in cash).
Other news: ZNGA +10.7% (announces ZyngaPlusPoker and ZyngaPlusCasino launching for UK players; co's first real money games), NVAX +8.5% (reports positive top-line results from Phase 2 clinical trial of RSV vaccine candidate in women of childbearing age), MHR +7.6% (Penn Virginia enters into a definitive agreement with Magnum Hunter Resources (MHR) to acquire producing properties and undeveloped leasehold interests in the Eagle Ford Shale play for ~ $400 mln), GLUU +7.3% (higher with ZNGA), NFX +7.2% ( announces 'significant' discovery offshore Malaysia, provides update on process to explore strategic alternatives for international businesses), ZOLT +5.9% ( announces review of its strategic alternatives), BUD +1.7% and NVO +1.6% (still checking), FB +1.1% (SEC says social media OK for company announcements if investors are alerted), CSCO +0.2% (announces intent to acquire Ubiquisys, a provider of 3G and long-term evolution small cell technology for approx $310 mln in cash and retention-based incentives).
Analyst comments: ALXA +7.1% (upgraded to Overweight from Neutral at Piper Jaffray), SIX +0.9% (added to Conviction Buy List at Goldman), NEE +0.9% ( added to Conviction Buy List at Goldman), NKE +0.8% (tgt to $67 from $56 at HSBC), CMG +0.7% (upgraded to Mkt Perform from Underperform at Raymond James)
Gapping down
In reaction to disappointing earnings/guidance: GPN -6.4%, ATML -3% (also appoints Steve Skaggs as interim Chief Financial Officer), CAG -2.1%
A few financial related names showing weakness: NBG -5.5%, ING -1.8%, SAN -1.3%, RBS -1.3%, BBVA -1.1%.
Select metals/mining stocks trading lower: GFI -2.9% (downgraded to Neutral from Outperform at Credit Suisse), HMY -2%, BHP -1.1%, BBL -0.8%, MT -0.7%, AU -0.7% (AngloGold downgraded to Neutral from Outperform at Credit Suisse).
A few telecom names trading lower: VOD -3.5% (Verizon discloses it is a willing purchaser of the 45% stake Vodafone holds in Verizon, but does not have any intention to merger with or make an offer for Vodafone), FTE -2.9%, PT -2.2%
Other news: TTM -4.8% (light volume, still checking), SEP -3.7% (commenced an underwritten public offering of 4,500,000 of its common units representing limited partner interests), ARCC -2.8% (announces public offering of 16.65 mln shares of common stock), TSLA -2.6% (announces new finance product in partnership with Wells Fargo (WFC) and US Bank ), LCC -0.9% (reports record March Load Factor of 86.1%, up 1.5 points YoY; PRASM results are lower than previous guidance), CHFN -0.4% (announces results of Stock Offering, Stockholder Vote and Member Vote).
Analyst comments: ADT -1.7% (downgraded to Underweight from Equal-Weight at Morgan Stanley),CRL -2.6% (ticking lower, downgraded to Sell from Neutral at Citigroup), CNS -2.1% (downgraded to Underperform from Buy at BofA), LM -1.4%
Торговые идеи NYSEи NASDAQ:
NFX– компания сообщила об открытии месторождения газа в Малайзии. Технически – очень слабая акция. Смотрим в шорт от уровней предыдущего пика – 24.00-24.20
TSLA – производитель автомобилей сообщил о новом партнерском соглашении (лизинг и кредитные программы) с Wells Fargo. Акция торгуется достаточно высоко, при закреплении выше 44.00 смотрим акцию в лонг.
CAG – отчет хуже ожидание аналитиков по EPS и выручке, подтверждение прогноза по EPS на FY13. Выше 34.00 смотрим акцию в лонг, потенциал движения 25-50 центов.
Спайдер торгуется на премаркете у локального уровня сопротивления.
Европейские индексы на положительной территории.
Nikkei -1.1%, Shanghai около нулевой отметки.
SPY (внутридневной график) рост на премаркете. Сопротивление 156.9. Поддержка: 155.75 – 156.00
Ожидаемая макроэкономическая статистика:
Mar ISM - NY (8:45am)
Feb Factory Orders (9am)
Kocherlakota Speaks on Monetary Policy in North Dakota (12pm)
Lockhart Speaks in Alabama (12:30pm)
Fed's Evans, Lacker Speak on Monetary Policy in Richmond (6:30pm)
Премаркет NYSE/NASDAQ:
Gapping up
In reaction to strong earnings/guidance: WYY +13.8% (thinly traded), URBN +4.4%.
M&A news: OMPI +15.7% (Merz Pharma Group makes superior proposal to acquire Obagi Medical Products for $22/share in cash), VOD +5.2% (AT&T and Verizon may be considering bid for VOD, according to reports).
Select financial related names showing strength: MTU +3.6%, CS +2.8%, DB +2.3%, UBS +2.2%, BCS +2.0%, ING +1.8%, HBC +1.4%.
Select healthcare related names showing strength: UAM +9.4%, HUM +9.3% (expects its 2014 Medicare Advantage bid benchmark premium to include an increase for medical cost trend of ~3.4% vs. the previously expected reduction of ~2.2%), UNH +3.4%, CI +3.1%, MOH +2.4%, AET +2.1%, HCA +1.2%, CVH +1%, WCG +0.9%, AGP +0.3%, .
Other news: BGCP +40.3% (BGC announces sale of its platform for the fully electronic trading of benchmark, on-the-Run U.S. Treasuries to NASDAQ OMX), BCRX +8.7% (Bird Flu deaths in China have generated a WHO probe, according to reports), NUAN +6.5% (Carl Icahn earlier disclosed 9.27% passive stake in 13G filing), HTZ +4.1% (discloses investor update in slide presentation), SWY +3.1% (trading higher following positive MadMoney mention), ACT +2.7% (confirms favorable ruling in generic Pulmicort RESPULES patent suit), SVU +2.5% ( S.A.C. Capital discloses 5.1% passive stake in 13G filing ), TTM +2.5% (Tata Motors March India sales fell 28% YoY, according to reports), UN +1.7% (still checking), NFLX +1.3% (trading higher following positive MadMoney mention), ARNA +1.1% (discloses U.S. District Court granted motions to dismiss stockholder actions), SAP +1% (still checking), BP +0.9% (BP spill administrator wants lawsuit dismissed, according to reports ), AMZN +0.7% (hired former Windows phone exec Charlie Kindel, according to reports), C +0.5% (Citigroup $590 settlement is being questioned by a Judge, according to reports), WMC +0.5% (raises its quarterly dividend to $0.95; announces revisions to annual and quarterly results), FB +0.5% (is in discussions to acquire online dating company, Bang With Friends for $30 mln, according to reports).
Analyst comments: EHTH +8.6% (upgraded to Buy from Neutral at BofA/Merrill), MCP +2.9% (initiated with a Buy at DA Davidson), DVA +1.3% (upgraded to Buy from Hold at Deutsche Bank), AZN +1.2% (upgraded to Neutral from Underweight at JP Morgan), QCOM +1.2% ( upgraded to Strong Buy from Outperform at Raymond James)
Gapping down
In reaction to disappointing earnings/guidance: AFFY -4.4% (light volume), SCVL -2.8%.
Select metals/mining stocks trading lower: MT -2.5%, GFI -1.3%, AUY -0.7%, AU -0.6%, SLV -0.5%, NEM -0.4%.
Other news: NBG -12.1% (still checking, reports out this morning indicate that Cyprus finance minister Sarris resigns), NAT -12% (announced public offering of $87 mln aggregate amount of common shares), NDAQ -7.5% (BGC announces sale of its platform for the fully electronic trading of benchmark, on-the-Run U.S. Treasuries to NASDAQ OMX), ASMI -2.4% (still checking), IRET -2.1% (announces public offering of common shares of beneficial interest), TECD -0.8% (announced delay of filing annual report because it requires additional time to complete the required financial statements and restatement), PRE -0.7% (attributed to pricing of block trade).
Analyst comments: HPQ -4.0% (downgraded to Sell from Neutral at Goldman), GRPN -0.7% (initiated with a Sell at UBS), LLTC -0.7% (downgraded to Hold from Buy at Stifel), TXN -0.6% (downgraded to Hold from Buy at Stifel), RAX -0.5% (downgraded to Market Perform from Outperform at Wells Fargo)
Торговые идеи NYSEи NASDAQ:
BGCP- вчера компания анонсировала продажу своей платформы для электронной торговли облигациями США бирже NASDAQ OMX. Смотрим на оба тикера (BGCP и NDAQ). BGCP – смотрим цену открытия и уровень 5.50. Ниже него – продажа, выше – покупка. Потенциал 50 центов.
NUAN – Carl Icahn раскрыл приобретение 9,27% акций компании. Отталкиваемся от уровня 22.00, ниже него смотрим акцию на продажу. При закреплении выше и удержании бида возможен лонг.
URBN – форма 10К, CEO ожидает рост продаж в 1 квартале 2014. Продаем акцию ниже 40.00
CVH – движение на новостях сектора. Снижение затрат для фармацевтических компаний. Смотрим на поведение акции после 10.00 NY. Хорошая идея – торговля баскетом компаний сектора. (HNT, HUM, MOH, CNC, UAM, WLP, AET, CVH, CI, HUM, HCA, WCG, GTS, EMCI, AGP, MGLN).
Оставить комментарий
